title: Brain volume and cognitive function in adult survivors of childhood acute lymphoblastic leukemia.
abstract: The survival rate for childhood acute lymphoblastic leukemia (ALL) is greater than 80%. However, many of these survivors develop long-term chronic health conditions, with a relatively common late effect being neurocognitive dysfunction. Although neurocognitive impairments have decreased in frequency and severity as treatment has evolved, there is a subset of survivors in the current treatment era that are especially vulnerable to the neurotoxic effects of ALL and its treatment. Additionally, little is known about long-term brain development as survivors mature into adulthood. A recent study by Zeller et al. compared neurocognitive function and brain volume in 130 adult survivors of childhood ALL to 130 healthy adults matched on age and sex. They identified the caudate as particularly sensitive to the neurotoxic effects of chemotherapy. We discuss the implications and limitations of this study, including how their findings support the concept of individual vulnerability to ALL and its treatment.
authors.affiliation: Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.
authors.forename: Michelle N
authors.initials: MN
authors.lastname: Edelmann
authors.affiliation: Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Krull
keywords: Magnetic resonance imaging (MRI); acute lymphoblastic leukemia (ALL); chemotherapy; late outcomes; neurocognitive
references.citation: J Clin Exp Neuropsychol. 1988 Aug;10(4):495-537
references.pmid: 3042805
references.citation: JAMA. 2013 Jun 12;309(22):2371-81
references.pmid: 23757085
references.citation: AJNR Am J Neuroradiol. 2005 May;26(5):1263-9
references.pmid: 15891195
references.citation: Eur Radiol. 2008 Nov;18(11):2691-700
references.pmid: 18491104
references.citation: J Clin Oncol. 2013 Dec 10;31(35):4407-15
references.pmid: 24190124
references.citation: J Clin Oncol. 2008 Sep 1;26(25):4138-43
references.pmid: 18757327
references.citation: Arch Pediatr Adolesc Med. 2007 Aug;161(8):798-806
references.pmid: 17679663
references.citation: Prog Neurobiol. 2008 Nov;86(3):141-55
references.pmid: 18824075
references.citation: AJNR Am J Neuroradiol. 2009 Nov;30(10):1947-54
references.pmid: 19643920
references.citation: J Clin Oncol. 2012 Oct 10;30(29):3618-24
references.pmid: 22949149
references.citation: J Clin Oncol. 2013 Jun 10;31(17):2078-85
references.pmid: 23589559
references.citation: Pediatrics. 2010 May;125(5):e1124-34
references.pmid: 20435702
references.citation: Med Pediatr Oncol. 1997 Jun;28(6):387-400
references.pmid: 9143382
references.citation: J Child Neurol. 2005 Feb;20(2):129-33
references.pmid: 15794179
references.citation: Cancer. 2006 Feb 15;106(4):941-9
references.pmid: 16411228
references.citation: N Engl J Med. 2006 Oct 12;355(15):1572-82
references.pmid: 17035650
references.citation: Proc Natl Acad Sci U S A. 2004 May 25;101(21):8174-9
references.pmid: 15148381
references.citation: J Psychiatry Neurosci. 2011 Jul;36(4):256-65
references.pmid: 21418787
references.citation: Pediatr Blood Cancer. 2013 Nov;60(11):1778-84
references.pmid: 23775832
references.citation: Neuron. 2010 Sep 9;67(5):728-34
references.pmid: 20826305
references.citation: Semin Clin Neuropsychiatry. 2003 Oct;8(4):201-16
references.pmid: 14613048
references.citation: Pediatr Blood Cancer. 2009 Oct;53(4):551-6
references.pmid: 19499584
references.citation: J Clin Oncol. 2007 Aug 20;25(24):3649-56
references.pmid: 17704415
references.citation: Oncol Nurs Forum. 2011 Sep;38(5):E365-72
references.pmid: 21875833
references.citation: Pediatr Blood Cancer. 2008 Jul;51(1):99-104
references.pmid: 18322925
references.citation: Pediatr Blood Cancer. 2011 Sep;57(3):454-60
references.pmid: 21618410
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1033-40
references.pmid: 19336557
references.citation: J Clin Oncol. 2005 Aug 20;23(24):5501-10
references.pmid: 16110010
references.citation: J Clin Oncol. 1991 Aug;9(8):1348-56
references.pmid: 2072138